Searchable abstracts of presentations at key conferences in endocrinology

ea0081p218 | Thyroid | ECE2022

Results of radioiodine remnant ablation with 30 mci dose in low-risk differentiated thyroid carcinoma (dtc)

De Lara-Rodriguez Irene , Duenas Disotuar Suset , Romero Lluch Ana R. , Luis Tirado-Hospital Juan , Pinar Gutierrez Ana , Navarro Elena

Background: The indication of ablation with I131 in low-risk DTC is controversial. The exact dose needed for thyroid remnant ablation is still a matter of debate in low-risk DTC patients. However, low dose has been found to be equally effective as high dose in terms of recurrence rate in recent studies. Taking this into account the current trend is to administer lower doses, although some studies describe a higher rate of retreatment.Aims: 1. To examine ...

ea0081ep385 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Adult-onset loss of the hepatocyte growth hormone receptor (GHR) is associated with increased autophagy in livers of male mice in the context of natural daytime fasting

Sarmento-Cabral Andre , Gutierrez-Casado Elena , del Rio-Moreno Mercedes , Vazquez-Borrego Mari C , Kineman Rhonda D

Liver autophagy, as assessed by accumulation of LC3-II and p62 proteins, is positively correlated with the severity of nonalcoholic steatohepatitis (NASH) in humans. Since growth hormone (GH) is negatively associated with liver steatosis and NASH development, and our laboratory has reported that steatosis and NASH develops in a mouse model of adult-onset, hepatocyte-specific GH-Receptor knockdown (aHepGHRkd), we sought to determine if GH directly regulates the hepatocyte autop...

ea0090ep794 | Pituitary and Neuroendocrinology | ECE2023

MAFLD prevalence in a cohort of patients with Cushing’s disease

Remon Pablo , Gutierrez Ana Pinar , Moreno Eva Venegas , Dios-Fuentes Elena , Gonzales David Cano , Romero-Gomez Manuel , Soto-Moreno Alfonso

Objectives: To describe the prevalence of liver steatosis in a cohort of patients with Cushing’s disease.Methods: Cross-sectional descriptive study. We included 59 patients with Cushing’s disease from our cohort of patients who underwent a Fibroscan to analyze the degree of hepatic steatosis (CAP measured in dB/m) and liver fibrosis (fibrosis measured in kPa). Biochemical algorithms of liver steatosis and fibrosis were assessed.<p class="ab...

ea0049ep8 | Adrenal cortex (to include Cushing's) | ECE2017

Corticoids-therapy related complications in patients with primary adrenal insufficiency

Rodriguez Juan Carlos Romero , Gutierrez Maria Calatayud , Reyes Laura Mola , Vaca Carlos Silva , Iglesias Sonsoles Guadalix , Diaz-Guerra Guillermo Martinez

Introduction: Patients with primary adrenal insufficiency (PAI) require lifelong corticoids replacement and they are at risk of therapy-related osteoporosis and cardiovascular complications.Objectives: Determine the prevalence of cardiovascular risk factors, osteoporosis, and other toxicities related with corticoids treatment.Material and methods: Retrospective, descriptive study in patients with PAI follow up in our service during...

ea0041ep326 | Clinical case reports - Pituitary/Adrenal | ECE2016

Anomalous venous drainage another difficulty for the diagnosis of Cushing’s Syndrome

Gutierrez Lorena Suarez , de La Uz Joaquin Pertierra , Morera Juan Luis Fernandez , Ragnarson Cecilia Sanchez , Torre Edelmiro Menendez

Introduction: It is known that about 75% of cases of endogenous Cushing síndorme to a pituitary adenoma (HA) ACTH-producing, 15% to ectopic ACTH and 10% is due to adrenal adenoma.Case: The patient was 64 years old, derived from Diabetes Mellitus type 2 of about 16 years of history with an unwieldy+hypertension diagnosed in 2007 with no physical signs compatible with hypercortisolism and incidentally detected a left adrenal adenoma 2 cm. Hormonal blo...

ea0037ep821 | Pituitary: clinical | ECE2015

Study of the prevalence and related factors in the withdrawal of medical treatment macroprolactinomas

Gutierrez Lorena Suarez , Caballero Maria Galiana Rodriguez , Ragnarson Cecilia Sanchez , Garcia Nuria Valdes , Garcia Laura Cacho , Torre Edelmiro Menendez

Introduction: The prolactinoma is the most common functioning pituitary tumour. There are few long-term studies on the optimal duration of treatment with dopamine agonists prolactinoma to ensure healing without recurrence after stopping the medication and do not provide a consensus on it or on withdrawal criteria treatment.Objectives: To establish the prevalence of withdrawal of treatment macroprolactinomas and evaluate criteria prolactinoma cure medical...

ea0037ep873 | Thyroid cancer | ECE2015

Clinical and biological differences between incidental and non-incidental papillary thyroid microcarcinomas

Paja Miguel , Etxebarria Eider , Gutierrez Ma Teresa , Exposito Amaia , Dublang Maddalen , Oleaga Amelia , de Ciriza Maite Perez , Ugalde Aitziber

The clinical significance and potential morbidity of papillary thyroid microcarcinomas (PTMC) is discussed. Particularly the differences between those PTMC identified postoperatively in histological examination (incidentals), and those diagnosed preoperatively (non-incidentals). We retrospectively analysed differences in clinical presentation and course after treatment in these two groups. The study population consisted of 199 patients with PTMC who underwent surgery from 2000...

ea0035p670 | Growth hormone IGF axis basic | ECE2014

Young female with acromegaloid features, pituitary macroadenoma, and an uncomplicated pregnancy

Figueroa Carlos , Santiago Monica , Hernan Jose , Mangual Michelle , Gutierrez Madeleine , Palermo Coromoto , Trinidad Rafael , Sanchez Alfredo , Miranda Maria DeLourdes

Thirty-two years old female G2P1A0 seen at our endocrinology clinic 9 years ago complaining of persistent menstrual irregularities associated to elevated prolactin values. MRI done revealed a pituitary microadenoma. However, she refused treatment for microprolactinoma. Four years afterwards, patient return complaining of recurrent episodes of headache. Repeated MRI showed a pituitary macroadenoma, so start on cabergoline treatment.Once more, patient was ...

ea0032p1132 | Thyroid cancer | ECE2013

Male patient with neck mass: ectopic cancer vs metastasic disease

Palermo Coromoto , Torres Oberto , Hernan Martinez Jose , Silva Frieda , Gutierrez Madeleine , Gonzalez Eva , de Lourdes Miranda Maria

Case of 33 years old male patient with an unremarkable past medical history, who after a car accident, a cystic nodular right neck mass was incidentally found by MRI of cervical spine. Physical examination revealed a mildly tender right neck mass. He was clinically and biochemically euthyroid. Denied history of neck irradiation. No family history of thyroid disease or thyroid cancer. Excisional biopsy of right neck mass showed metastasic well differentiated papillary carcinoma...

ea0026p512 | Bone/calcium/Vitamin D | ECE2011

rs219780 SNP of CLDN14 gene is not associated with kidney stones, fractures or bone mineral density in primary hyperparathyroidism

Piedra M , Berja A , Garcia-Unzueta M T , Gutierrez-Hierro M T , Garcia-Llama N , Renteria C , Lavin B A , Amado J A

Background: CLDN14 gene encodes a protein involved in regulation of paracellular permeability or ion transport at epithelial tight junctions as in the nephron. C allele of the rs219780 SNP of CLDN14 gene has been associated with high levels of PTH and with low bone mineral density (BMD) in women. Our aim is to study the relationship between rs219780 SNP of CLDN14 and fractures, renal lithiasis and bone mineral density in patients with primary hyperparathyr...